Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Drug Resistance, Multiple, Bacterial”

109 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 109 results

Testing effectiveness (Phase 2)Looking for participantsNCT05791396
What this trial is testing

FMT to Eradicate Intestinal Colonization by Carbapenem-resistant Enterobacteriaceae

Who this might be right for
Enterobacteriaceae InfectionsMulti-antibiotic Resistance
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 36
Early research (Phase 1)Study completedNCT04309656
What this trial is testing

Single-dose Study in Two Panels of Healthy Adult Participants to Assess Immediate-Release and Dispersible Formulations of Pretomanid

Who this might be right for
Multi-drug Resistant Tuberculosis
Global Alliance for TB Drug Development 48
Not applicableNot Yet RecruitingNCT06700577
What this trial is testing

Multidrug Resistance in Newly Diagnosed TB Patient

Who this might be right for
Tuberculosis
Assiut University 100
Post-approval studies (Phase 4)Study completedNCT00495339
What this trial is testing

MDR TB, Levofloxacin, Multi-Drug-Resistant Pulmonary Tuberculosis

Who this might be right for
Tuberculosis, Pulmonary
Sanofi 100
Testing effectiveness (Phase 2)Study completedNCT07496502
What this trial is testing

Effect of Oral Microbiota on MDRO Decolonization

Who this might be right for
Clostridioides Difficile InfectionDrug Resistance, BacterialGastrointestinal Microbiome+2 more
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 42
Not applicableStudy completedNCT01845246
What this trial is testing

Multicentric Study About the Usefulness of Monitoring Plasma Levels of Colistin and Sodium Colistimethate in Patients With Infections Due to Multi-drug Resistant Gram Negative Bacilli, Treated With Colistin

Who this might be right for
Multidrug Resistant Gram Negative Bacterial Infections
Parc de Salut Mar 101
Large-scale testing (Phase 3)WithdrawnNCT01600963
What this trial is testing

Evaluate the Efficacy and Safety of TMC207 in Patients With Pulmonary Infection With Multi-drug Resistant Mycobacterium Tuberculosis

Who this might be right for
Multi-drug Resistant Tuberculosis
Janssen Infectious Diseases BVBA
Not applicableUnknownNCT05709184
What this trial is testing

Lyophilized Fecal Microbiome Transfer vs. Vancomycin Monotherapy for Primary Clostridioides Difficile Infection

Who this might be right for
Clostridioides Difficile Infection
Rambam Health Care Campus 196
Early research (Phase 1)Study completedNCT03910673
What this trial is testing

Intravenous Fosfomycin Pharmacokinetics Study

Who this might be right for
Bacterial InfectionMultiple-drug ResistancePathogen Resistance
National Institute of Allergy and Infectious Diseases (NIAID) 39
Not applicableStudy completedNCT06760143
What this trial is testing

Antibiotic Prophylaxis in Lung-Transplant Recipients

Who this might be right for
Lung-transplant RecipientsAntibiotic Prophylaxis
IRCCS Azienda Ospedaliero-Universitaria di Bologna 90
Not applicableTemporarily pausedNCT01132417
What this trial is testing

In Vitro Activity of Tigecycline Among Key Bacterial Pathogens Exhibiting Multidrug Resistance

Who this might be right for
Infections, Bacterial
King Faisal University 500
Not applicableLooking for participantsNCT04172025
What this trial is testing

Development of a Swiss Surveillance Database for Molecular Epidemiology of Hypervirulent and Multi-drug Resistant Pathogens

Who this might be right for
Multiresistant Bacterial PathogensVirulent Bacterial Pathogens
University Hospital, Basel, Switzerland 10,000
Large-scale testing (Phase 3)Study completedNCT02607449
What this trial is testing

FS-1 Drug for Treatment of Multiple Drug-resistant Tuberculosis

Who this might be right for
Tuberculosis, MDR
Scientific Center for Anti-infectious Drugs, Kazakhstan 344
Not applicableActive Not RecruitingNCT05117788
What this trial is testing

Bioneer Q-RFIA Clinical Evaluation

Who this might be right for
Tuberculosis, Multidrug-Resistant
Foundation for Innovative New Diagnostics, Switzerland 2,350
Post-approval studies (Phase 4)Looking for participantsNCT07477119
What this trial is testing

Linezolid Tolerance During the BPaL Regimen With Dosage Personalization Based on Therapeutic Drug Monitoring (TDM) During Multidrug-Resistant Tuberculosis Treatment

Who this might be right for
LinezolidTuberculosis Multi Drug Resistant ActiveTherapeutic Drug Monitoring (TDM)
Marco Schiuma 150
Not applicableStudy completedNCT07058233
What this trial is testing

Oral Nutritional Supplementation and Weight Changes During Therapy in Malnourished Patients With Resistant Tuberculosis: A Clinical Trial

Who this might be right for
Tuberculosis Multi Drug Resistant ActiveRifampin-Resistant Pulmonary TuberculosisPre-xdr tb
RSUP Persahabatan 70
Testing effectiveness (Phase 2)Study completedNCT00425113
What this trial is testing

Metronidazole for Pulmonary Tuberculosis (South Korea)

Who this might be right for
TuberculosisMulti-Drug Resistant Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 35
Not applicableUnknownNCT03409315
What this trial is testing

Feasibility of Centralized Therapeutic Drug Monitoring of Fluoroquinolones in Multi-Drug Resistant Tuberculosis Patients

Who this might be right for
Tuberculosis, Multidrug-Resistant
University Medical Center Groningen 360
Not applicableLooking for participantsNCT06148480
What this trial is testing

Perinatal Transmission of MDR Bacteria

Who this might be right for
E. Coli InfectionMulti-antibiotic Resistance
Ann & Robert H Lurie Children's Hospital of Chicago 200
Testing effectiveness (Phase 2)Study completedNCT02573350
What this trial is testing

A Trial to Evaluate Safety, Tolerability, and Efficacy of Orally Administered OPC-67683

Who this might be right for
Tuberculosis, Multidrug-Resistant
Otsuka Pharmaceutical Development & Commercialization, Inc. 213
Load More Results